NAPIGEN, INC.

About

NAPIGEN, INC. is a biotechnology company founded in 2016 and based in Wilmington, Delaware. The company specializes in novel genome engineering, focusing on mitochondria and chloroplasts, which are essential for energy production in cells. NAPIGEN aims to leverage its technology to enhance agriculture, human healthcare, and industrial biotechnology. The company's proprietary technology allows for genome editing of organelles, enabling innovative applications in various organisms, including plants, microbes, and animals. NAPIGEN is particularly focused on developing agricultural products that aim to increase grain yields and reduce greenhouse gas emissions. The company has received funding from several investors and is working to establish partnerships with agricultural companies to bring its products to market. Recognized as the best startup in the Industrial Biotechnology category at the Hello Tomorrow Global competition in 2020, NAPIGEN is committed to advancing its research and development efforts. With a dedicated team and a strong financial foundation, the company is well-positioned to make significant contributions to biotechnology.